Issues in cytogenetic biological dosimetry: emphasis on radiation environments in space.
Issues central to the reliability of cytogenetic biodosimetry are presented. Although it now appears that cytogenetic biodosimetry can be used reliably to reconstruct radiation dose after acute, uniform whole-body exposure (albeit within certain dose ranges), additional data are required to fully validate cytogenetic biodosimetry for the protracted and complex exposure conditions in space. Approaches are presented that could be used to obtain the data necessary for validation. It also appears that the use of dicentric aberrations for biodosimetry on missions lasting several months or more may not be reliable because of the large variability observed among individuals in the rate of loss of cells with dicentrics, making back-extrapolations uncertain. This may be testable, however, by comparing the results for dicentrics and translocations obtained by biodosimetry with the radiation dosimetry obtained on board the spacecraft. In addition to these and several other issues, estimates are provided of the current limitations of detection of dicentrics and reciprocal translocations.
Straume
T
T
Health and Ecological Assessment Division, Lawrence Livermore National Laboratory, University of California, Livermore 94551, USA.
Bender
M A
MA
D000337:Aerospace Medicine; D018480:Astronauts; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000528:radiation effects*; D004781:Environmental Exposure; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008214:Lymphocytes / Q000648:ultrastructure; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011829:Radiation Dosage; D011834:Radiation Monitoring; D011874:Radiometry / Q000379:methods; D011878:Radiotherapy; D012306:Risk; D013026:Space Flight; D013997:Time Factors